Legal & General Group PLC Foghorn Therapeutics Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 2,706 shares of FHTX stock, worth $20,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,706
Previous 2,706 -0.0%
Holding current value
$20,349
Previous $25,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.8 - $9.99 $566 - $1,178
-118 Reduced 4.18%
2,706 $25,000
Q2 2024

Aug 14, 2024
BUY
$5.05 - $8.0 $4,115 - $6,520
815 Added 40.57%
2,824 $16,000
Q3 2023

Nov 14, 2023
SELL
$5.0 - $9.87 $2,500 - $4,935
-500 Reduced 19.93%
2,009 $10,000
Q2 2023

Aug 14, 2023
BUY
$5.37 - $8.84 $1,541 - $2,537
287 Added 12.92%
2,509 $17,000
Q2 2022

Aug 22, 2022
BUY
$8.48 - $16.84 $4,723 - $9,379
557 Added 33.45%
2,222 $30,000
Q1 2022

May 16, 2022
BUY
$8.87 - $22.1 $532 - $1,326
60 Added 3.74%
1,665 $25,000
Q4 2021

Feb 14, 2022
SELL
$10.79 - $22.87 $733 - $1,555
-68 Reduced 4.06%
1,605 $37,000
Q3 2021

Nov 15, 2021
SELL
$8.33 - $15.02 $408 - $735
-49 Reduced 2.85%
1,673 $23,000
Q2 2021

Aug 12, 2021
BUY
$9.32 - $13.26 $9,375 - $13,339
1,006 Added 140.5%
1,722 $18,000
Q4 2020

Feb 12, 2021
BUY
$15.12 - $25.88 $10,825 - $18,530
716 New
716 $15,000

Others Institutions Holding FHTX

# of Institutions
80
Shares Held
33.3M
Call Options Held
8.7K
Put Options Held
2.4K
View Full List

About Foghorn Therapeutics Inc.

FHTX Quotes by TradingView
  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $313M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email